Atara Biotherapeutics (ATRA) logo

Atara Biotherapeutics (ATRA) stock

Worth $81.3MShares as of Aug 10

$8.10
-0.98%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score ATRA. It is too thinly traded for a fair Quality Score.

Healthcare · Biotech

NextMar 31, 2027 · In 141 days“The BLA has a Class 2 Resubmission Prescription Drug User Fee Act (PDUFA) target action date of March 31, 2027…”FDA decision date · SEC filing · Nov 10
Cash$9.9M, about 1 quarter at the last year's spendingOn Jun 30 · the company says “into mid-2027”

Follow ATRA's news. Pro members can get an alert when Atara Biotherapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when ATRA files newsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

Cash$9.9M, about 1 quarter at the last year's spendingOn Jun 30 · the company says “into mid-2027”

What's next for ATRA, and how long its cash lasts

Next step the company has named

Mar 31, 2027In 141 days“The BLA has a Class 2 Resubmission Prescription Drug User Fee Act (PDUFA) target action date of March 31, 2027.”FDA decision date · SEC filing · Nov 10

What it means: the date by which the FDA has said it aims to decide on the company’s application. The FDA can decide earlier, or extend the date.

For Pro members: 46 filings.

Cash runway Jun 30 balance sheet

About 1 quarter

$9.9M in cash and short-term investments, at its spending over the last year

What it means: how long the cash would last at the same pace, before any new money. The company's estimate is “into mid-2027” (8-K, Nov 10).

For Pro members: whether the cash lasts past the FDA date, the cash used each quarter, and the math.

Dilution on the horizon

  • Shelf registration (S-3, filed Nov 10, 2026)
  • At-the-market share sales program (S-3, filed Nov 10, 2026)

For Pro members: 5 raises and their amounts, and the share count against a year ago.

Insiders

Director Brian N Cherry bought 104,166 shares on Sep 4. 7 more insider trades this year.

From Form 4: open-market buys and sales only.

For Pro members: every trade, and AnhCo Nguyen’s 9 filings and quotes.

Get an alert before ATRA's FDA date

A free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

ATRA's latest filings

35 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why ATRA isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. ATRA trades about 24,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

Every US stock, ranked live.

Insider and Congress trades, the chart, and the financials, in one score.

See every stock ranked

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

The price on this page is delayed at least 15 minutes.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.